Glenmark Pharmaceuticals board to consider unaudited financial statements

18 Jan 2013 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on January 29, 2013, to consider and approve the company’s un-audited financial statements for the Third Quarter ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×